Bart C. J. M. Fauser

Reproductive Medicine · 2002–2018

A researcher in the Science corpus: 16 papers; trusts 7 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

Reproductive Medicine — 74 citations into it; #23 of 208 by trust here, #7 by citations
Public Health, Environmental and Occupational Health — 60 citations into it; #707 of 2,368 by trust here, #252 by citations
Endocrinology, Diabetes and Metabolism — 26 citations into it
Pediatrics, Perinatology and Child Health — 17 citations into it

Whom Bart C. J. M. Fauser trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts Bart C. J. M. Fauser overall

Papers from Bart C. J. M. Fauser's perspective

Ordered by how strongly the researchers Bart C. J. M. Fauser trusts endorse each paper. Same corpus, a different order for every researcher.

Polycystic ovary syndrome (Nature Reviews Disease Primers)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (European Journal of Endocrinology)
AGREE II: advancing guideline development, reporting and evaluation in health care (Canadian Medical Association Journal)
Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. (Endocrinology)
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (Journal of Clinical Endocrinology and Metabolism)
Ultrasound assessment of the polycystic ovary: international consensus definitions. (Human Reproduction Update)
Antimüllerian hormone serum levels: a putative marker for ovarian aging. (Fertility and Sterility)
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (Human Reproduction)
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. (Human Reproduction)
Regulation of ovarian function: the role of anti-Müllerian hormone. (Reproduction)

Their papers

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) — 2,461 citations
Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. (2016) — 721 citations
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. (2016) — 598 citations
Intraovarian control of early folliculogenesis. (2015) — 607 citations
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014) — 608 citations
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. (2012) — 1,611 citations
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. (2011) — 1,686 citations
Ovarian aging: mechanisms and clinical consequences. (2009) — 1,135 citations
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. (2006) — 801 citations
Fertility and ageing. (2005) — 642 citations
The early days of IVF. (2005) — 23 citations
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. (2004) — 1,325 citations
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). (2004) — 8,538 citations
Antimüllerian hormone serum levels: a putative marker for ovarian aging. (2002) — 933 citations
Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. (2002) — 762 citations
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (2002) — 1,017 citations